Keyphrases
Myocardial Infarction
100%
Meta-analysis
100%
Long-term Efficacy
100%
Cell Transplantation
100%
Mononuclear Cells
100%
Cell Therapy
57%
Left Ventricular Ejection Fraction
57%
Acute Myocardial Infarction
42%
Adverse Cardiac Events
42%
Left Ventricular End-diastolic Volume (LVEDV)
42%
6-minute Walk Test (6MWT)
28%
I(2)
28%
New York Heart Association Class
28%
Infarct Size
28%
Ischemic Cardiomyopathy
28%
Clinical Trials
14%
Myocardial Ischemia
14%
Trial Design
14%
Randomized Clinical Trial
14%
Clinical Significance
14%
Embase
14%
Cochrane Library
14%
Event Rate
14%
PubMed
14%
Brain Natriuretic Peptide
14%
Short-term Follow-up
14%
Fraction Size
14%
Cardiovascular Pathology
14%
Cardiac Markers
14%
Cardiovascular Capacity
14%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
14%
Medicine and Dentistry
Cell Transplantation
100%
Myocardial Infarction
100%
Meta-Analysis
100%
Mononuclear Cell
100%
Cell Therapy
57%
Heart Left Ventricle Ejection Fraction
57%
Acute Heart Infarction
42%
Major Adverse Cardiac Event
42%
Cardiovascular System
28%
Infarction
28%
New York Heart Association Class
28%
End-Systolic Volume
28%
Brain Natriuretic Peptide
28%
Ischemic Cardiomyopathy
28%
Six Minute Walk Test
28%
Randomized Clinical Trial
14%
Clinical Trial
14%
Clinical Significance
14%
Amino Terminal Sequence
14%
End-Diastolic Volume
14%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Acute Heart Infarction
100%
Major Adverse Cardiac Event
100%
Infarction
66%
Ischemic Cardiomyopathy
66%
Brain Natriuretic Peptide
66%
Clinical Trial
33%
Randomized Clinical Trial
33%